Introduction
============

Anxiety may be defined as an intensified fear or avoidance in response to objects or situations in the absence of true danger ([@B61]), and may be operationally defined as an emotional response to potential unidentified threats, being characterized by sustained arousal, vigilance, worry and apprehension that results in specific patterns of defensive behaviors and concomitant autonomic responses ([@B68]). It is a normal physiological response commonly found after or in anticipation of stressful experiences, but can also appear frequently as a symptom in patients suffering from neurological and psychiatric disorders, as well as in chronic disease ([@B49]; [@B9]). Anxiety is present in daily life, being among the main symptoms arising from occupational stress, and associated to metabolic syndrome ([@B67]), obesity ([@B24]) and binge eating ([@B57]). Disorders consisting of exacerbated anxiety responses are known as anxiety-related disorders and include, according to the DSM-V, PTSD, GAD, Phobias, panic disorder, social phobia, agoraphobia, OCD, and specific phobias ([@B2]). Anxiety-related disorders are the most common disorders in psychiatry, affecting at least 18% of Americans ([@B32]) and 7.3% Worldwide ([@B4]). Despite the high prevalence of anxiety, the neurobiological basis of anxiety is only beginning to be unveiled.

Several brain regions have been associated to anxiety in humans and rodents, among which, the amygdala has shown to be pivotal in orchestrating behavioral responses to both fear and anxiety ([@B68]). Other brain areas that have been associated to anxiety include the bed nucleus of the stria terminalis, hippocampus, septum, paraventricular nucleus of the hypothalamus, ventral tegmental area and locus coeruleus, among others (reviewed in [@B40]).

The IC, also known as the insula in humans, is a brain region that has been associated to anxiety, albeit being far less studied than the above brain regions. Neuroimaging studies suggest that the insula plays a critical role in the pathophysiology of anxiety-related disorders ([@B55]; [@B17]). In fact, increased insular activity has been reported in patients suffering from generalized anxiety ([@B28]), panic disorders ([@B69]), phobias ([@B28]; [@B25]; [@B73]), OCD ([@B55]; [@B37]) and PTSD ([@B55]; [@B39]). In all the above disorders, insular activity decreased in response to effective treatment ([@B28]; [@B25]; [@B37]). Despite the vast evidence demonstrating a relationship between anxiety-related disorders and insular activity in humans, the role of the insula in anxiety *per se* remains unclear. A handful of studies in humans suggest that the insula may have a role in anxiety; anxiety may modulate insula recruitment ([@B19]); the severity of anxiety may be positively correlated with central amygdala-insula functional connectivity ([@B72]); and lorazepam induces a dose-dependent reduction in the activation of both the amygdala and insula during emotion processing ([@B53]). Hence, insular activation may be considered a common feature among anxiety-related disorders, and it may have a role in anxiety *per se*, in concert with amygdala activation.

The insula or IC is located deep within the temporal lobe in humans and surrounds the rhinal fissure in rodents. It is generally associated with pain ([@B30]; [@B42]), somatosensory ([@B66]), gustatory ([@B34]; [@B64]; [@B63]), viscerosensory ([@B59]), auditory ([@B8]) and olfactory ([@B62]) functions, and direct IC stimulation causes somatosensory, viscerosensory, motor, vestibular, auditory and speech effects in humans ([@B50]). The insula has also a role in drug addiction ([@B12]; [@B20]), motor control, language ([@B48]), memory ([@B7]; [@B23], Fornari et al., 2016), emotions ([@B14]) and awareness ([@B36]). The insula has hence been described as an integrating center, linking information from diverse functional systems, into one subjective image of "our world" ([@B36]).

The insula receives interoceptive information, including muscular and visceral sensations and is involved in the regulation of hunger and thirst ([@B13]; [@B6]). Given its interoceptive inputs, Paulus and Stein proposed that "the insula is crucial in determining the difference between the interoceptive sensation expected from a stimulus and the prediction of its outcome, represented as a prediction signal in the anterior IC" ([@B53]). They proposed that a difference between the two may initiate an anxiety state and the affective, cognitive and behavioral components that characterize anxiety may be a consequence of this altered prediction signal ([@B53]).

Understanding the role of the insula in anxiety requires studies in animal models, yet research for the role of the insula in anxiety in animals is currently limited to two studies in rats. [@B38] reported that muscarinic cholinergic manipulation in the IC of rats modulates anxiety-like behavior in the EPM, which is one of the most accepted models for measuring anxiety-like behavior in rodents (for reviews on the different animal models to measure anxiety-like behaviors see [@B15]; [@B35]). In another study, [@B56] showed that insular adrenergic activity modulates arousal-induced increases in neophobia, or hyponeophagia, which is another anxiety-like behavior used to measure anxiety in rats ([@B21]). Interestingly, the two studies performed pharmacological manipulations at different regions of the insula. A more systematic evaluation of the role of the different regions of the IC in anxiety is lacking. Here, we microinfused the AMPA receptor antagonist CNQX and the GABA receptor antagonist BMI into 4 sub-regions along the rostro-caudal axis of the IC in order to inhibit or activate the IC, respectively, and used the EPM to measure anxiety-like behavior in rats. Our results suggest a direct, rostro-caudal differential involvement of the IC in anxiety.

Materials and Methods {#s1}
=====================

Animals
-------

Male Sprague-Dawley rats weighting 250--300 g were housed individually in a 12-h light-dark cycle and kept in their homecages throughout the study. Animals were removed briefly for stereotaxic surgery, microinjection and behavioral assays. Water and food were provided *ad libitum.* All procedures involving animals were approved by the bioethical Committee of the Universidad Andres Bello, Acta 11/2016 and were in accordance with the United States National Institutes of Health guide lines.

Cannula Implantation
--------------------

Rats were chronically implanted with chronic cannulas as previously described ([@B56]). Briefly, rats were anesthetized by a combination of ketamine/xylazine/acepromazine (5, 5, and 5 ml/kg, respectively) and mounted in a stereotaxic apparatus. They were given a subcutaneous lidocaine injection under the scalp and their skull was surgically exposed. 21-gauge stainless steel guide cannulas were bilaterally implanted and positioned 1 mm above the IC, according to stereotaxic coordinates relative to bregma aiming at 4 different regions of the insula along its rostro-caudal axis: Rostral agranular (raIC; AP +2.8, ML ±4.0, DV −4.2) ([@B30]); gustatory (gIC; AP +1.2, ML ± 5.6, DV −6.7) ([@B47]; [@B56]); primary interoceptive posterior (pIC; AP −0.5, ML ±5.5, DV −6.0) ([@B10]); caudal (cIC; AP −2.3, ML ±6.4, DV −5.4) ([@B5]). Cannulas were secured by four screws and fixed to the skull using acrylic dental cement. A stylus was inserted into the guide cannula. After surgery, animals received a subcutaneous injection of meloxicam (Pro-vet, Chile; 0.6 mg/kg) and a bacitracin/neomycin dermal ointment (Laboratorio Chile) was applied over the surgical area. A post-surgery recovery period of 7 days was given before behavioral evaluation began and a 3-min daily handling session was carried out during the last 3 days of the recovery period to habituate the animals to microinjection-associated handling stress.

Microinfusion
-------------

A 25-gauge injection cannula was inserted into the guide cannula protruding 1 mm beyond its tip, into the target area. Bilateral microinfusion of either CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, 0.89 μg/μL/0.5 μL/hemisphere; SIGMA), Bicuculline methiodide (BMI) (7.34 ng/μL/0.5 μL/hemisphere; SIGMA) or their respective vehicles (2% DMSO in saline (0.9% NaCl) for CNQX and saline alone for BMI) was performed using an injection cannula that were connected by PE20 tubing to Hamilton micro-syringes driven by a digital microinfusion pump. Microinjections were delivered at a rate of 0.25 μl/min and a diffusion time of 2 min was given by holding the injection cannula in place. The microinfused volume was selected to diffuse into dorso-ventral layers of the IC, allowing to focus on possible rostro-caudal differences ([@B22]). Microinfusion was performed 15 min (for CNQX) and 10 min (for BMI) prior to the EPM evaluation in accordance to previous studies ([@B58]; [@B45]). Microinjections were performed prior and not during the behavioral task in order to avoid behavioral abnormalities resulting from microinjection-related discomfort.

The number of animals used per group is shown in [Table 1](#T1){ref-type="table"}.

###### 

Number of animals included in the analysis for each injection.

  Injection location   Drug                       N° animals
  -------------------- -------------------------- ------------
  raIC                 CNQX                       6
                       Vehicle (2% DMSO+saline)   5
                       BMI                        6
                       Vehicle (saline)           5
  gIC                  CNQX                       15
                       Vehicle (2% DMSO+saline)   16
                       BMI                        6
                       Vehicle (saline)           5
  pIC                  CNQX                       11
                       Vehicle (2% DMSO+saline)   11
                       BMI                        8
                       Vehicle (saline)           6
  cIC                  CNQX                       5
                       Vehicle (2% DMSO+saline)   9
  (openfield)          CNQX                       8
  (openfield)          Vehicle (2% DMSO+saline)   9
                       BMI                        7
                       Vehicle (saline)           9

Elevated Plus Maze (EPM)
------------------------

A single 5-min exposure to the EPM was performed as described elsewhere ([@B71]) with slight modifications. The EPM consisted of four arms, each with a length of 60 cm and 15 cm width. Two opposing arms were open, and the other two were enclosed by 15 cm high black acrylic walls. The maze was standing 75 cm above the floor and was dimly illuminated. After microinjection, rats were placed in the central zone of the maze facing an open arm and allowed 5 min of free exploration. Before each test, the arena was cleaned with 70% ethanol. The evaluation was video recorded for offline analysis, and the time spent on the open arms was manually registered by a blinded investigator. Spontaneous locomotor activity was evaluated by the number of transitions, which represents the number of entrances and exits to and from any of the EPM arms. Time spent in the open arms is presented as percentage of the total evaluation time ± standard error of the mean (SEM). Results were compared by a two tailed Student's *t*-test when comparing the infused drug and its vehicle for each location and by one-way ANOVA with a Bonferroni *post hoc* test when multiple comparisons were required. A value of *p* \< 0.05 was considered statistically significant. In the case of finding significant differences in transitions using EPM, these were corroborated in the open field.

Open Field
----------

Experiments that showed differences in transitions using the EPM were repeated using the openfield. In this test, microinjected animals were placed at the center of a plexiglas rectangular box (60 × 40 × 40 cm) and allowed to explore for 5 min. The behavior was recorded digitally for subsequent off-line analysis by a blinded investigator, using 10 × 10 cm virtual squares on the floor of the OF. The number of transitions (crossings of the virtual squares) were measured and compared between groups.

Histology
---------

Immediately after behavioral testing, animals were euthanized and perfused with phosphate buffered saline (PBS) followed by 4% PFA dissolved in PBS. Brains were kept for 48 h in a 30% sucrose solution and then sectioned in a cryostat. For histological analysis, Nissl staining was performed and analyzed using light microscopy. Histological exclusion criteria included cannula misplacement, tissue damage extending beyond the tip of the injection or guide cannulas (as assessed by cellular debris, lack of neuronal somata or gliosis). Animals that met any of these criteria were excluded from further analysis. The Paxinos and Watson rat brain atlas in stereotaxic coordinates was used as primary reference to locate the injection sites ([@B54]). The histological analysis was performed blinded to the results obtained from the behavioral evaluation.

Results
=======

To evaluate the role of the IC in anxiety, 4 sub-regions along the rostro-caudal axis of the IC were selected for drug microinfusion. The regions selected were: Rostral Agranular Insular Cortex (raIC); gIC; Primary Interoceptive Posterior Insular Cortex (pIC) and Caudal Insular Cortex (cIC). The rostro-caudal location of the 4 sub-regions of the IC is depicted in [Figure 1A](#F1){ref-type="fig"} and representative photomicrographs of cannula placement for each sub-region are shown in [Figure 1B--E](#F1){ref-type="fig"}. Nissl staining was used to evaluate cannula placement and histological damage. Animals that had damage larger than the guide cannula or did not have the tip of the injection cannula at the target area bilaterally were excluded from the analysis.

![The four IC sub regions studied. **(A)** Schematic rostro-caudal localization of the four IC sub-regions microinjected. Anteroposterior (AP) coordinates relative to bregma are shown for each sub-region in brackets. Black lines show the localization of the respective coronal sections shown in **B--E**. **(B--E)** Representative coronal sections of a microinjection for each insular subregion (left) and its corresponding scheme from [@B54] atlas; injection site is shown with an asterisk. **(B)** raIC, rostral agranular insular cortex; **(C)** gIC, gustatory agranular insular cortex; **(D)** pIC, primary interoceptive insular cortex; **(E)** cIC, caudal insular cortex. Scale bar: 0.5 mm.](fphys-10-00330-g001){#F1}

Micro-infusion of CNQX into raIC caused a significant increase in time spent in the open arms when compared to vehicle microinjected rats (7 ± 2%, *p* \< 0.05, *n* = 5 for vehicle and 20 ± 4%, *n* = 6 for CNQX, *p* \< 0.05) ([Figure 2A](#F2){ref-type="fig"}), suggesting an anxiolytic effect. Similarly, CNQX infusion into gIC resulted in decreased anxiety-like behavior (14 ± 2%, *p* \< 0.05, *n* = 16 for vehicle and 24 ± 3%, *n* = 15 for CNQX, *p* \< 0.05) ([Figure 2B](#F2){ref-type="fig"}). No significant differences in the number of transitions were observed for either sub-region (raIC: 23 ± 4, *n* = 5 for vehicle and 26 ± 4, *n* = 6 for CNQX. gIC: 24 ± 3, *n* = 16 for vehicle and 29 ± 3, *n* = 15 for CNQX; *p* \> 0.05) ([Figure 2C--D](#F2){ref-type="fig"}), suggesting that changes in the time spent in the open arms are not due to locomotor abnormalities, sedation or decreased exploration. Given that inactivation of both the raIC and gIC by CNQX induced a decrease in anxiety as measured in the EPM, the role of both rostral regions of the insula may be considered putatively anxiogenic.

![CNQX microinfusion into the rostral sub-regions induces anxiolytic effects in the elevated plus maze (EPM). **(A)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 5) or CNQX (black bars, *n* = 6) was microinjected into raIC; **(B)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 16) or CNQX (black bars, *n* = 15) was microinjected into gIC. Total transitions during the EPM evaluation for rats microinjected into raIC **(C)** or gIC **(D)**. Columns represent the mean ± SEM. ^∗^*p* \< 0.05.](fphys-10-00330-g002){#F2}

Microinjection of CNQX into the pIC had no significant effects on anxiety but showed a tendency to decrease the time spent in the open arms when compared to vehicle microinjected rats, which did not reach significance (26 ± 4%, *n* = 11 for vehicle and 21 ± 3%, *n* = 11 for CNQX, *p* \> 0.05) ([Figure 3A](#F3){ref-type="fig"}). Vehicle and CNQX microinjected rats showed no differences in transitions for pIC, discarding locomotor abnormalities or changes in exploratory behavior (pIC: 31 ± 3, *n* = 11 for vehicle and 31 ± 3, *n* = 11 for CNQX; *p* \> 0.05) ([Figure 3C](#F3){ref-type="fig"}).

![CNQX microinfusion into the caudal sub-regions of the IC induces anxiogenic effects in the EPM. **(A)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 11) or CNQX (black bars, *n* = 11) was microinjected into pIC; **(B)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 9) or CNQX (black bars, *n* = 5) was microinjected into cIC. Total transitions during the EPM evaluation for the same rats microinjected into pIC **(C)** or cIC. **(D)**. **(E)** Effect of CNQX microinjected into the cIC in locomotion (transitions) in the open field **(E)**. Columns represent the mean ± SEM. ^∗^*p* \< 0.05.](fphys-10-00330-g003){#F3}

The inactivation of the cIC significantly decreased the time spent in the open arms when compared to vehicle microinjected rats (17 ± 3%, *n* = 9 for vehicle and 5 ± 3%, *n* = 5 for CNQX, *p* \< 0.05) ([Figure 3B](#F3){ref-type="fig"}). However, CNQX microinjected into the cIC induced a significant decrease in transitions (cIC: 31 ± 3, *n* = 9 for vehicle and 10 ± 4, *n* = 5 for CNQX; *p* \< 0.05; [Figure 3D](#F3){ref-type="fig"}). To determine whether this difference is due to motor abnormalities, locomotion was measured in the open field and no differences were found when compared to veh injected rats, suggesting that the difference in transitions found in the EPM was not due to decreased locomotion, suggesting possible increased anxiety (cIC: 87 ± 11, *n* = 8 for vehicle and 110 ± 11, *n* = 9 for CNQX; *p* \> 0.05; [Figure 3E](#F3){ref-type="fig"}).

To corroborate the above results, the four insular regions were now activated by the microinjection of GABA receptor antagonist bicuculline (BMI). Congruent with an anxiogenic role for raIC, BMI microinjection into the raIC induced anxiogenic-like effects, producing a significant decrease in the time spent in the open arms when compared to vehicle injected rats (39 ± 10%, *n* = 5 for vehicle and 14 ± 5%, *n* = 6 for BMI, *p* \< 0.05; [Figure 4A](#F4){ref-type="fig"}). Likewise, BMI microinjection into the gIC also induced a significant decrease in the time spent in the open arms when compared to its corresponding vehicle (18 ± 4%, *n* = 6 for vehicle and 5 ± 2%, *n* = 6 for BMI, *p* \< 0.01; [Figure 4B](#F4){ref-type="fig"}). No differences in the number of transitions were observed for either sub-region (raIC: 24 ± 6, *n* = 5 for vehicle and 22 ± 12, *n* = 6 for CNQX. gIC: 23 ± 5, *n* = 6 for vehicle and 21 ± 5, *n* = 6 for CNQX; *p* \> 0.05) ([Figure 4C,D](#F4){ref-type="fig"}), suggesting that changes in the time spent in the open arms are not due to locomotor abnormalities, sedation or decreased exploration. In summary, inactivation with CNQX induced anxiolytic effects, while activation with BMI induced anxiogenic effects in both the raIC and gIC regions of the insula, suggesting an anxiogenic role for the rostral portion of the IC.

![Bicuculline microinfusion into the rostral sub-regions in the EPM induces anxiogenic effects. **(A)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 5) or BMI (black bars, *n* = 6) was microinjected into raIC; **(B)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 5) or BMI (black bars, *n* = 6) was microinjected into gIC. Total transitions during the EPM evaluation for the same rats microinjected into pIC **(C)** or cIC **(D)**. Columns represent the mean ± SEM. ^∗^*p* \< 0.05 and ^∗∗^*p* \< 0.01.](fphys-10-00330-g004){#F4}

Bicuculline microinjection into the pIC induced an increase in the time spent in the open arms (16 ± 5%, *n* = 7 for vehicle and 22 ± 6%, *n* = 8 for BMI, *p* \> 0.05), which -- as with CNQX -- again did not reach significance ([Figure 5A](#F5){ref-type="fig"}).

![Bicuculline microinfusion into the caudal sub-regions induces anxiolytic effects in the EPM. **(A)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 6) or BMI (black bars, *n* = 8) was microinjected into pIC; **(B)** Percentage of time spent in the open arms when vehicle (white bars, *n* = 9) or BMI (black bars, *n* = 7) was microinjected into cIC. Total transitions during the EPM evaluation for the same rats microinjected into pIC **(C)** or cIC **(D)**. Columns represent the mean ± SEM. ^∗^*p* \< 0.5.](fphys-10-00330-g005){#F5}

In line with the results obtained from CNQX microinjection into the most caudal region of the insula, BMI microinjection into the cIC induced anxiolytic effects ([Figure 5B](#F5){ref-type="fig"}), producing a significant increase in the time spent in the open arms when compared to vehicle injected rats (12 ± 2%, *n* = 9 for vehicle and 19 ± 2%, *n* = 7 for BMI, *p* \< 0.05). There were no differences in the number of transitions in either group (pIC or cIC) when compared to their respective controls (cIC: 22 ± 3, *n* = 9 for vehicle and 23 ± 5, *n* = 7 for BMI; pIC: 22 ± 2, *n* = 7 for vehicle and 27 ± 5, *n* = 8 for BMI; *p* \> 0.05) ([Figure 5C,D](#F5){ref-type="fig"}), suggesting that changes in the time spent in the open arms were not due to locomotor abnormalities, sedation or increased exploration. Given that the activation of the cIC induced a decrease in anxiety and its inactivation induced an increase in anxiety as measured in the EPM, the role of the most caudal region of the insula (cIC) may be considered putatively anxiolytic.

To determine whether the lack of significance in the anxiogenic effects of CNQX and BMI in the pIC may be due to its possible location within a transition zone between anxiogenic and anxiolytic regions of the insula, each microinjection location for CNQX and BMI was plotted along the rostro-caudal axis and the ventro-dorsal subdivisions of the insula (see [Figure 6A](#F6){ref-type="fig"}), together with the anxiogenic or anxiolytic role of that region based on the difference between the anxiety-like behavior of each animal and the average of the corresponding control group. As can be seen in [Figure 6B](#F6){ref-type="fig"}, the transition area in which both anxiogenic and anxiolytic roles for the insula can be found after microinjections of both CNQX and BMI, runs along approximately bregma +0.5 and −0.5. As pIC microinjections fell within the caudal end of this transition area (around bregma −0.5 mm), the effects of pharmacologically modulating the activity of this area showed mixed results with a tendency for an anxiolytic role, making it difficult to reach significance.

![Anxiolytic and anxiogenic roles of the insular cortex based on location and effect of CNQX and Bicuculline microinjections. **(A)** 3D representation of insula cortex based on [@B54], showing dorso-ventral subdivisions along the rostral axis in respect to bregma. AID, agranular insular cortex dorsal part; AIP, agranular insular cortex posterior part; AIV, agranular insular cortex ventral part; Au1, primary auditory cortex; DI, dysgranular insular cortex; GI, granular insular cortex; PhR, perirhinal cortex; S1, primary somatosensory cortex; S2, secondary somatosensory cortex. **(B)** Anxiolytic and anxiogenic roles along insular cortex based on CNQX and Bicuculline microinfusions. Each triangle/circle represent an injection case (circles, CNQX; triangles, Bicuculline). The anxiolytic/anxiogenic classification was qualitative and defined as the role of that particular location in anxiety. The role in anxiety for each injection site was estimated based on the difference between the time in the open arms of each case and the average of the respective control. Given that CNQX is an inhibitor, final values for CNQX were multiplied by --1. Final values \<0 were considered anxiogenic and \>0, anxiolytic.](fphys-10-00330-g006){#F6}

The present results suggest that rostral regions of the insula may have an anxiogenic role, while caudal regions may have an anxiolytic role, with a transition region between bregma +0.5 and −0.5. As can be seen in [Figure 6B](#F6){ref-type="fig"}, no dorso-ventral differences in the effects of microinjections were observed, except possibly for the dysgranular IC, which appears to remain anxiogenic for most of the transition zone.

Discussion
==========

The sub-regions selected for the present work, have previously been used for studies regarding learning and memory ([@B27]), drug addiction ([@B10]), taste function ([@B63]; [@B47]; [@B56]) and pain ([@B30]; [@B5]). However, their direct role in anxiety had not been explored. It has been suggested that the anterior insula contributes to the perception of interoceptive sensations associated to danger or threat, possibly playing a crucial role in anxiety ([@B53]). However, delimitations of insular regions in the rostrocaudal axis are not as straightforward as in the dorso-ventral axis ([@B43]). We used the AMPA receptor antagonist CNQX to study the role of IC in anxiety and to address whether functional differences could be observed along the rostro-caudal axis of the IC by inactivating the IC in different regions along its rostro-caudal axis. CNQX disturbs glutamatergic transmission and hence neuronal activation ([@B74]), providing an inversed insight into the role of a brain region in behavior. CNQX microinfusion into raIC and gIC caused an increase in the time spent in the open arms, suggesting an anxiogenic role for these rostral IC sub-regions. These results were corroborated with GABA receptor antagonist BMI, which showed that activation of both regions induces anxiogenic effects in the rat. These results support a pivotal role for the anterior insular regions in anxiety and help to understand the neuroimaging studies evidencing higher IC activity in patients suffering from anxiety-related disorders ([@B49]; [@B9]).

A previous study determined a role for IC muscarinic receptors in anxiety ([@B38]). It is important to note that this work considered IC coordinates at the level of the most caudal sub-region studied here, cIC. Concordantly, CNQX microinjection into the cIC decreased the time spent in the open arms, suggesting an anxiolytic role for the most caudal region of the insula, which was corroborated by BMI injections.

Perhaps the most parsimonious explanation for this regional difference along the rostro-caudal axis of the IC is the existence of different neuronal populations in the rostral and caudal portions, with their respective anxiogenic and anxiolytic outputs. This may be similar to the bed nucleus of the stria terminalis, which has shown to consist of different cell populations with differential anxiogenic and anxiolytic effects ([@B33]). In the case of the insula, the rostral regions may include anxiogenic neuronal populations while the most caudal regions may show anxiolytic neuronal populations, which may coexist within the transition area described in the present report. Further studies will be required to understand the anatomical correlates that subserve the differential role of the insula along its rostro-caudal axis.

Another alternative explanation may be related to the flow of interoceptive information within the IC. An internal, caudal to rostral relay of interoceptive information within the IC has been previously proposed ([@B11]; [@B20]). Therefore, it is plausible that CNQX or BMI microinjections into caudal regions (e.g., cIC) impairs caudal to rostral connectivity within the insula, changing activity in the rostral sub-regions. Based on this idea, CNQX microinjected into the more caudal regions of the insula would be expected to induce anxiolytic effects, since the behavioral output would be commanded by the decreased input into the anxiogenic rostral regions. Further studies must be performed to determine the role of caudal to rostral connectivity within the insula in anxiety.

Notwithstanding, the present results show a direct involvement of the IC in anxiety. Furthermore, we show that the IC involvement in anxiety is not homogenous along its rostro-caudal axis. The location of the insula within the brain circuitry of anxiety is currently unknown. In that respect, the amygdala and insula interact closely with each other and appear to share many functional aspects (for a review see [@B46]). This is particularly important as the amygdala is pivotal in orchestrating behavioral responses to fear and anxiety ([@B68]). Both insula and amygdala have been shown to increase their activation during emotion processing in normal volunteers ([@B52]), anxiety-prone subjects ([@B65]) and phobia patients ([@B76]), activation that can be reduced by anxiolytics ([@B52]). Increased functional connectivity between the insula and the amygdala has also been reported in untreated GAD patients ([@B41]), and during acute stress following a traumatic event ([@B51]). Increased functional connectivity between the amygdala and the insula has also been positively correlated with the severity of anxiety symptoms ([@B72]).

There are extensive amygdala-insula connections in rodents ([@B1]). Studies in rodents have also shown projections bringing somatosensory and pain information to the amygdala from somatosensory cortical areas running across the insula ([@B60]). Furthermore, glutamate injections into the basolateral amygdala induce decreases in spontaneous discharges at the gIC ([@B26]). Moreover, it has been suggested that the insula may receive discomfort signals from the body, and then integrates and sends the signals to the amygdala ([@B18]; [@B3]). The insula and the amygdala are also reciprocally connected with the ventral tegmental area, which releases dopamine and its activation induces anxiolytic effects ([@B31]). Connections between the insula and other anxiety relevant brain regions have also been reported in rodents, including the lateral hypothalamic area ([@B1]), bed nucleus of the stria terminalis ([@B59]) and nucleus accumbens ([@B75]; [@B29]). Based on the present study, the insula appears to be critical for anxiety. Hence, its position with respect to other regions within the anxiety-related brain circuitry is an issue that warrants the need for further investigation.

In our study, saline and 2% DMSO (in saline) were used as vehicles for BMI and CNQX, respectively. The effects in the EPM for each injection at any location was compared to the effects of the microinjection of its respective vehicle in that same location. It must be noted, however, that there was high variability in the baseline values after vehicle microinjections, which could reflect differences in the level of anxiety among groups of animals or individuals. However, the possibility that the vehicle injections may have affected anxiety cannot be readily ruled out, in which case, the drugs could have altered the effects of the vehicle (either prevented or enhanced them), rather than induced effects in anxiety by themselves. Hence, care must be taken when interpreting the present results. Further research will be required to determine the possible effects of vehicle injections into the IC in anxiety.

A final point that deserves to be discussed is related to whether the role of the insula in the rat can be directly translated to the human insula. In this respect, several studies have suggested vast similarities between the human and the rodent insula, including their functional organization (reviewed in [@B46]). However, on the basis of mediodorsal thalamic afferents, the dorsal anterior agranular insula in rodents has been proposed as part of the rodent equivalent to the primate prefrontal cortex ([@B44]; [@B70]). The dorsal agranular insular and ventral anterior insular areas have also been proposed to resemble the primate orbitofrontal cortex ([@B77]; [@B16]). Hence, further research will be required to determine whether the regions of the rat insula studied in the present report correspond only to the insula in primates, or also comprise cortical regions homologous to human prefrontal or orbitofrontal cortices.
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AMPA

:   α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

BMI

:   bicuculline methiodide

cIC

:   caudal insular cortex

CNQX

:   cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione)

DSM-V

:   Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

EPM

:   elevated plus maze

GABA

:   γ-aminobutyric acid

GAD

:   generalized anxiety disorder

gIC

:   gustatory insular cortex

IC

:   insular cortex

OCD

:   obsessive compulsive disorder

pIC

:   primary interoceptive posterior insucar cortex

PTSD

:   post-traumatic stress disorder

raIC

:   rostral agranular insular cotrex

[^1]: Edited by: Eugene Nalivaiko, The University of Newcastle, Australia

[^2]: Reviewed by: Luca Carnevali, University of Parma, Italy; Fernando Morgan de Aguiar Corrêa, University of São Paulo, Brazil

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology
